https://www.globenewswire.com/news-release/2024/07/08/2909883/0/en/Boehringer-Ingelheim-produces-its-own-green-energy.html
German Vice Chancellor and Federal Minister of Economics Robert Habeck inaugurates new biomass power plantIngelheim site can cover 95% of its energy needs...
boehringer ingelheimgreen energyproduces
https://www.veeva.com/eu/customer-stories/boehringer-ingelheim-setting-the-foundation-for-future-expansion-with-veeva-vault-crm/
Boehringer Ingelheim builds on its Veeva journey by ensuring a seamless transition to Veeva Vault CRM while optimizing commercial operations and driving highly...
boehringer ingelheimfuture expansionsettingfoundationveeva
https://www.fiercebiotech.com/biotech/boehringer-backs-out-730m-lung-cancer-pact-hanmi-following-data-review
Boehringer Ingelheim has backed out of the $730 million (
lung cancerboehringerbackspacthanmi
https://www.pharmaceutical-technology.com/news/boehringer-oxford-cumulus/
Boehringer Ingelheim, along with the University of Oxford, UK, and Cumulus Neuroscience, has launched a study for BPD.
brain activityboehringeroxfordcumulusexplore
https://www.biospace.com/acquisition-agreement-with-boehringer-ingelheim-for-nbe-therapeutics-marks-first-major-biotech-exit-for-ppf-group
PPF Group, an international investment group, today announced the signing of a binding agreement to sell its stake in NBE-Therapeutics to Boehringer Ingelheim....
boehringer ingelheimacquisitionagreementnbetherapeutics
https://informaconnect.com/bpieurope/speakers/eva-diem/
Go beyond theory at BioProcess International Europe. Master the future of biomanufacturing: from cell line development, upstream, downstream, ATMPs to...
boehringer ingelheimevadiembioprocessinternational
https://www.clinicaltrialsarena.com/news/jardiance-phaseiii-trial-data/
Boehringer and Lilly have reported positive data from the EMPEROR-Reduced trial of Jardiance in adults with heart failure with reduced ejection fraction.
boehringerlillyjardiancemeetsgoals
https://www.sap.com/documents/2024/05/12f1f6ee-bf7e-0010-bca6-c68f7e60039b.html
Learn how Boehringer Ingelheim is helping keep its medicines secure and safeguarding the integrity of the data accompanying its products on the way to patients...
boehringer ingelheimserializationmandateskeepingsupply
https://www.clinicaltrialsarena.com/uncategorized/newsboehringer-eth-zurich-sign-diabetes-obesity-research-collaboration/
Boehringer Ingelheim, the Institute of Molecular Health Science and the Institute of Food, Nutrition and Health of the ETH Zurich have entered into a diabetes...
eth zurichobesity researchclinical trialsboehringersign
https://www.ivoox.com/gripe-aviar-kateri-bertran-serafin-garcia-audios-mp3_rf_161152731_1.html
Escucha este episodio de Boehringer Ingelheim Avian Radio gratis en iVoox. Nuevo episodio de Boehringer Ingelheim Avian Radio. Cristina Sierra, charla con...
boehringer ingelheimgripeconkateribertran
https://www.meine-zukunft-bei-boehringer-ingelheim.de/
Gestalte Deine und unsere Zukunft mit uns. Bei Boehringer Ingelheim findest du den perfekten Ausbildungsberuf für dich. Auch Praktika und Studienplätze...
meine zukunftboehringer ingelheimichstartebei
https://www.pharmaceutical-technology.com/news/newsfda-approves-lilly-boehringer-basaglar-insulin-glargine-product-treat-diabetes-4756271/
The US Food and Drug Administration has granted approval for Basaglar (insulin glargine injection), a long-acting human insulin analog to improve glycemic...
insulin glarginefdalillyboehringerbasaglar
https://www.3tres3.com/noticias_empresa/boehringer-ingelheim-en-la-jornadas-de-la-avpa-2025_52819/
La Jornada Técnica de la AVPA centró su programa en la situación del colectivo veterinario desde dos perspectivas: la salud laboral y la reputación social.
boehringer ingelheimen lajornadasdeavpa
https://www.nomentia.com/de/references/boehringer-ingelheim
Erfahren Sie in unserer Case Study mit Boehringer Ingelheim, wie das Unternehmen seine FX-Hedging-Strategie mit Nomentia Risk Management optimiert hat.
boehringer ingelheimcase study
https://www.pharmaceutical-technology.com/news/boehringer-healx-drug-discovery/
Boehringer Ingelheim has partnered with UK-based drug technology firm Healx to identify new approaches to treat rare neurological disorders.
drug discoveryboehringerpartnershealxai
https://www.pharmaceutical-technology.com/news/boehringer-focus-schizophrenia-therapies-development/
Boehringer Ingelheim has announced plans to shift its focus onto drug development for the treatment of schizophrenia after its investigational compound BI...
pharmaceutical technologyboehringerfocusschizophreniatherapies
https://www.agriland.ie/farming-news/agriland-and-boehringer-ingelheim-launch-series-on-smarter-parasite-control/
Agriland and Boehringer Ingelheim are joining forces to bring livestock farmers a practical information series on parasite control
boehringer ingelheimlaunch seriesparasite controlsmarter
https://www.pharmaceutical-technology.com/data-insights/zongertinib-boehringer-ingelheim-international-non-small-cell-lung-cancer-likelihood-of-approval/
Zongertinib is under clinical development by Boehringer Ingelheim International and currently in Phase I for Non-Small Cell Lung Cancer.
boehringer ingelheimsmall cellzongertinibinternationalnon
https://www.pharmaceutical-technology.com/uncategorized/news100277-html/
Boehringer Ingelheim and MacroGenics have entered into a partnership to develop and commercialise antibody-based therapeutics covering multiple therapeutic...
pharmaceutical technologyboehringerdevelopantibodybased
https://www.provenexpert.com/en-us/melissa-boehringer/
Ratings & reviews for Melissa Boehringer (San Antonio), San Antonio Real Estate Garden Real Estate Ridge Real Estate Cibolo Real Estate Selma Real Estate
melissaboehringerreviewsexperiences
https://www.researchandmarkets.com/reports/4028727/boehringer-ingelheim-gmbh-company-profile-and
Boehringer Ingelheim GmbH - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's...
boehringer ingelheim gmbhcompany profileswot analysis
https://www.pharmaceutical-technology.com/news/newsldc-boehringer-max-planck-partner-discover-treatment-schizophrenia-4891315/
German companies Lead Discovery Centre (LDC), Boehringer Ingelheim International and Max Planck Innovation have signed an agreement to provide Boehringer with...
max planckldcboehringerpartnerdiscover
https://www.pharmaceutical-technology.com/data-insights/survodutide-boehringer-ingelheim-international-metabolic-dysfunction-associated-steatohepatitis-mash-likelihood-of-approval/
Survodutide is under clinical development by Boehringer Ingelheim International and currently in Phase III for Metabolic Dysfunction-Associated Steatohepatitis...
boehringer ingelheimmetabolic dysfunctionsurvodutideinternationalassociated
https://informaconnect.com/bpieurope/sponsors/boehringer-ingelheim/
Go beyond theory at BioProcess International Europe. Master the future of biomanufacturing: from cell line development, upstream, downstream, ATMPs to...
boehringer ingelheimbioprocessinternationaleurope
https://www.technologynetworks.com/proteomics/news/evotec-and-boehringer-ingelheim-extend-and-broaden-research-collaboration-193914
Strategic research collaboration continues for another 4 years at a value of EUR 15 million plus milestones and royalties.
boehringer ingelheimresearch collaborationevotecextendbroaden
https://www.salute.gov.it/new/it/concorso-avviso/boehringer-ingelheim-italia-spa-aifaministero-della-salute-ordinanza-tar-lazio-1/
Avviso di notifica per pubblici proclami ai destinatari della determina n. 1421/2021 dell'Agenzia Italiana del Farmaco di cui all'elenco disponibile nel file...
ministero della saluteboehringer ingelheimitaliapaifa
https://www.smartbiggar.ca/insights/client-success/case/boehringer-ingelheim-canada-ltd-v-jamp-pharma-corporation
Boehringer Ingelheim was successfully represented by a trial team from Smart & Biggar.
boehringer ingelheimcanadaltdvjamp
https://www.pharmaceutical-technology.com/data-insights/bi-1823911-boehringer-ingelheim-international-metastatic-colorectal-cancer-likelihood-of-approval/
BI-1823911 is under clinical development by Boehringer Ingelheim International and currently in Phase I for Metastatic Colorectal Cancer.
metastatic colorectal cancerboehringer ingelheimbiinternational
https://www.sap.com/assetdetail/2024/11/16ec5f48-e07e-0010-bca6-c68f7e60039b.html
In this panel, you'll learn more about Boehringer Ingelheim and SAP's approaches toward total workforce management. Learn how these two companies are managing...
total workforce managementboehringer ingelheimjourney
https://www.technologynetworks.com/genomics/news/boehringer-ingelheim-and-geneart-collaborate-to-provide-dna-therapeutics-and-vaccines-189077
The collaboration offers customers an integrated system solution from the design to the production of DNA-based pharmaceutical agents.
boehringer ingelheimcollaborateprovidednatherapeutics
https://www.fiercebiotech.com/biotech/boehringer-okays-100m-biobuck-deal-hearing-loss-rd-project
Boehringer Ingelheim has come sweeping down into Oklahoma to land rights to a treatment for the most common type of permanent hearing loss, joining up with...
hearing lossboehringeroksbiobucksdeal
https://www.pharmaceutical-technology.com/data-insights/spesolimab-boehringer-ingelheim-international-netherton-syndrome-trichorrhexis-invaginata-bamboo-hair-likelihood-of-approval/
Spesolimab is under clinical development by Boehringer Ingelheim International and currently in Phase III for Netherton Syndrome (Trichorrhexis Invaginata,...
boehringer ingelheimnetherton syndrometrichorrhexis invaginataspesolimabinternational
https://www.biomerieux.com/corp/en/journalists/press-releases/boehringer-ingelheim--evotec-and-biomerieux-launch-aurobac--a-jo.html
Boehringer Ingelheim, Evotec SE and bioMérieux announced today that they have formed a joint venture to create the next generation of antimicrobials along...
boehringer ingelheimjoint ventureevoteclaunch
https://www.clinicaltrialsarena.com/news/boehringer-nintedanib-paediatric/
Boehringer started patient enrolment for Phase III InPedILD trial of nintedanib in children and adolescents with fibrosing interstitial lung disease (ILD).
boehringerstartsenrolmentpaediatrictrial
https://www.pharmaceutical-technology.com/data-insights/atp-152-boehringer-ingelheim-international-pancreatic-ductal-adenocarcinoma-likelihood-of-approval/
ATP-152 is under clinical development by Boehringer Ingelheim International and currently in Phase I for Pancreatic Ductal Adenocarcinoma.
boehringer ingelheimatpinternationalpancreaticadenocarcinoma
https://www.pharmaceutical-technology.com/news/boehringer-reinforces-interest-in-nash-with-new-2bn-deal/
This collaboration comes six years after the German company Boehringer signed two agreements to develop treatments for NASH.
boehringerinterestnashnewdeal
https://www.pharmaceutical-technology.com/news/abbvie-boehringer-biosimilar-settlement/
AbbVie has settled a patent dispute in the US with Boehringer Ingelheim over Cyltezo, a biosimilar to its blockbuster drug Humira.
patent disputeabbvieboehringersettlehumira
https://www.pharmaceutical-technology.com/news/retinai-boehringer-geographic-atrophy/
RetinAI has collaborated with Boehringer Ingelheim to leverage AI to advance novel treatments for geographic atrophy (GA) patients.
geographic atrophyboehringerpartnertreat